These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 21832969)
41. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects. Yonal O; Eren F; Yılmaz Y; Atuğ Ö; Över HH Turk J Gastroenterol; 2014 Dec; 25(6):639-43. PubMed ID: 25599774 [TBL] [Abstract][Full Text] [Related]
42. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Ferguson LR; Browning BL; Huebner C; Petermann I; Shelling AN; Demmers P; McCulloch A; Gearry RB; Barclay ML; Philpott M Dig Liver Dis; 2008 Sep; 40(9):723-30. PubMed ID: 18394979 [TBL] [Abstract][Full Text] [Related]
43. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort. Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M; Digestion; 2016; 93(3):182-92. PubMed ID: 26928573 [TBL] [Abstract][Full Text] [Related]
44. An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study. Connelly TM; Koltun WA; Sangster W; Berg AS; Hegarty JP; Harris L; Deiling S; Stewart DB Surgery; 2014 Oct; 156(4):769-74. PubMed ID: 25239315 [TBL] [Abstract][Full Text] [Related]
45. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. Akin H; Tahan G; Türe F; Eren F; Atuğ O; Tahan V; Hamzaoğlu I; Imeryüz N; Tözün N; Hamzaoglu HO J Crohns Colitis; 2011 Feb; 5(1):14-8. PubMed ID: 21272798 [TBL] [Abstract][Full Text] [Related]
46. Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Huebner C; Browning BL; Petermann I; Han DY; Philpott M; Barclay M; Gearry R; McCulloch A; Demmers P; Ferguson LR Inflamm Bowel Dis; 2009 Dec; 15(12):1784-93. PubMed ID: 19685447 [TBL] [Abstract][Full Text] [Related]
47. Genetic risk and protective factors of TNFSF15 gene variants detected using single nucleotide polymorphisms in Hungarians with psoriasis and psoriatic arthritis. Képíró L; Széll M; Kovács L; Keszthelyi P; Kemény L; Gyulai R Hum Immunol; 2014 Feb; 75(2):159-62. PubMed ID: 24269700 [TBL] [Abstract][Full Text] [Related]
48. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Malecki MT; Klupa T; Wanic K; Cyganek K; Frey J; Sieradzki J Diabetes Res Clin Pract; 2002 Aug; 57(2):99-104. PubMed ID: 12062854 [TBL] [Abstract][Full Text] [Related]
50. Association between Toll-like receptor 4 and inflammatory bowel disease. Oostenbrug LE; Drenth JP; de Jong DJ; Nolte IM; Oosterom E; van Dullemen HM; van der Linde K; te Meerman GJ; van der Steege G; Kleibeuker JH; Jansen PL Inflamm Bowel Dis; 2005 Jun; 11(6):567-75. PubMed ID: 15905704 [TBL] [Abstract][Full Text] [Related]
51. Role of the MHC2TA gene in autoimmune diseases. Martínez A; Sánchez-Lopez M; Varadé J; Mas A; Martín MC; de Las Heras V; Arroyo R; Mendoza JL; Díaz-Rubio M; Fernández-Gutiérrez B; de la Concha EG; Urcelay E Ann Rheum Dis; 2007 Mar; 66(3):325-9. PubMed ID: 17012290 [TBL] [Abstract][Full Text] [Related]
53. Polymorphisms in the IL2RA and IL2RB genes in inflammatory bowel disease risk. Bouzid D; Amouri A; Fourati H; Marques I; Abida O; Tahri N; Goncalves CP; Masmoudi H Genet Test Mol Biomarkers; 2013 Nov; 17(11):833-9. PubMed ID: 23972291 [TBL] [Abstract][Full Text] [Related]
54. Association of the-801G/A polymorphism of CXCL12 gene with the risk of inflammatory bowel diseases development in a Polish population. Mrowicki J; Przybyłowska K; Dziki L; Sygut A; Wiśniewska-Jarosińska M; Chojnacki J; Dziki A; Majsterek I Pol Przegl Chir; 2011 Jun; 83(6):334-8. PubMed ID: 22166550 [TBL] [Abstract][Full Text] [Related]
55. Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. Ahirwar DK; Kesarwani P; Singh R; Ghoshal UC; Mittal RD J Gastrointest Cancer; 2012 Jun; 43(2):196-204. PubMed ID: 21249467 [TBL] [Abstract][Full Text] [Related]
56. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Dresner-Pollak R; Ackerman Z; Eliakim R; Karban A; Chowers Y; Fidder HH Genet Test; 2004; 8(4):417-20. PubMed ID: 15684874 [TBL] [Abstract][Full Text] [Related]
57. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy. Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954 [TBL] [Abstract][Full Text] [Related]
58. Vitamin D binding protein genotype and osteoporosis. Fang Y; van Meurs JB; Arp P; van Leeuwen JP; Hofman A; Pols HA; Uitterlinden AG Calcif Tissue Int; 2009 Aug; 85(2):85-93. PubMed ID: 19488670 [TBL] [Abstract][Full Text] [Related]
59. The role of FAS gene variants in inflammatory bowel disease. Demir A; Kahraman R; Candan G; Ergen A Turk J Gastroenterol; 2020 May; 31(5):356-361. PubMed ID: 32519954 [TBL] [Abstract][Full Text] [Related]
60. Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease. Chiba H; Kakuta Y; Kinouchi Y; Kawai Y; Watanabe K; Nagao M; Naito T; Onodera M; Moroi R; Kuroha M; Kanazawa Y; Kimura T; Shiga H; Endo K; Negoro K; Nagasaki M; Unno M; Shimosegawa T PLoS One; 2018; 13(3):e0194036. PubMed ID: 29547621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]